Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.tim.2021.03.016

http://scihub22266oqcxt.onion/10.1016/j.tim.2021.03.016
suck pdf from google scholar
33896688!8026254!33896688
unlimited free pdf from europmc33896688    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33896688      Trends+Microbiol 2021 ; 29 (7): 648-662
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses #MMPMID33896688
  • Siggins MK; Thwaites RS; Openshaw PJM
  • Trends Microbiol 2021[Jul]; 29 (7): 648-662 PMID33896688show ga
  • Even in nonpandemic times, respiratory viruses account for a vast global burden of disease. They remain a major cause of illness and death and they pose a perpetual threat of breaking out into epidemics and pandemics. Many of these respiratory viruses infect repeatedly and appear to induce only narrow transient immunity, but the situation varies from one virus to another. In the absence of effective specific treatments, understanding the role of immunity in protection, disease, and resolution is of paramount importance. These problems have been brought into sharp focus by the coronavirus disease 2019 (COVID-19) pandemic. Here, we summarise what is now known about adaptive immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and draw comparisons with immunity to other respiratory viruses, focusing on the longevity of protective responses.
  • |*Adaptive Immunity[MESH]
  • |Antibodies, Viral/immunology[MESH]
  • |COVID-19/epidemiology/*immunology/prevention & control[MESH]
  • |Humans[MESH]
  • |Respiratory Tract Infections/epidemiology/*virology[MESH]
  • |SARS-CoV-2/*immunology/pathogenicity[MESH]
  • |Time Factors[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box